PDS BIOTECHNOLOGY CORP's ticker is and the CUSIP is 70465T907. A total of 3 filers reported holding PDS BIOTECHNOLOGY CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,450 | -80.6% | 9,000 | -80.7% | 0.00% | -100.0% |
| Q2 2023 | $234,398 | +477.5% | 46,600 | +606.1% | 0.00% | – |
| Q1 2023 | $40,590 | -71.3% | 6,600 | -38.3% | 0.00% | – |
| Q4 2022 | $141,240 | +14024.0% | 10,700 | +3466.7% | 0.00% | – |
| Q3 2022 | $1,000 | -75.0% | 300 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | +33.3% | 300 | +50.0% | 0.00% | – |
| Q2 2021 | $3,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 6,600 | $40,590 | 0.00% |
| SIMPLEX TRADING, LLC | 24,100 | $148 | 0.00% |